Aron Feingold
Corporate Communications
T: 628-252-7494
investor@sangamo.com
Investor Relations
华为手机怎么v p n
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.
Read more
华为手机怎么v p n
Data Provided by Refinitiv. Minimum 15 minutes delayed.